Uniform Multidrug Therapy Regimen for Leprosy Patients

NCT00669643 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

859

Enrollment

OTHER

Sponsor class

Conditions

Leprosy

Interventions

DRUG: PB 6 doses - Rifampicin and Dapsone
DRUG: PB 6 doses - Rifampicin, Clofazimine and Dapsone
DRUG: MB 12 doses - Rifampicin, Clofazimine and Dapsone
DRUG: MB 6 doses - Rifampicin, Clofazimine and Dapsone

Sponsor

University of Brasilia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]